| |
 |
Tom Romesser, who earned his MS (1973) and PhD (1974) from the Department of Physics and Astronomy, has significant accomplishments in both areas. |
| Biography |
| His technical leadership in isotope separation provided a key step in producing the palladium-103 isotope that has been used in the treatment of prostate cancers in over 100,000 men, with a record 84% cancer-free success rate. His work has also been instrumental in the development of high-energy lasers for use in land, air, and space defense systems. Dr. Romesser has spent his career in the aerospace industry, first at TRW Incorporated and, as Vice President of Technology Development, at Northrup Grumman. In 2002, he was made a fellow of the Directed Energy Professional Society, in recognition of 25 years of significant contributions to the nation’s directed energy development program. In 2003, he was elected to the National Academy of Engineering. |
© Caltech.
All rights reserved. last update:
August 13, 2007
|
